Literature DB >> 22560341

Regulation of leptin receptor expression in human papillary thyroid cancer cells.

Shih-Ping Cheng1, Chien-Liang Liu, Yi-Chiung Hsu, Yuan-Ching Chang, Shih-Yuan Huang, Jie-Jen Lee.   

Abstract

Epidemiological studies suggest an important link between obesity and thyroid cancer. The adipose tissue-derived polypeptide leptin acting via leptin receptor may modulate cell migration of thyroid cancer cells. Previously we have demonstrated that leptin receptor is overexpressed in papillary thyroid cancer and is associated with tumor aggressiveness. The present study was undertaken to explore the possible regulatory factors which would influence leptin receptor expression in papillary thyroid cancer cells. We found that DNA methyltransferase inhibitor (5-Aza-2'-deoxycytidine) and histone deacetylase inhibitor (trichostatin A) reduced leptin receptor expression. Conversely, insulin upregulated leptin receptor expression in a time- and dose-dependent manner. Hypoxia-mimicking agent (cobalt chloride) had no effect on leptin receptor expression. Taken together, our study provides evidence that epigenetic events and insulin stimulation take part in regulation of leptin receptor expression in papillary thyroid cancer cells.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22560341     DOI: 10.1016/j.biopha.2012.03.008

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  8 in total

Review 1.  Mechanisms Linking Obesity and Thyroid Cancer Development and Progression in Mouse Models.

Authors:  Won Gu Kim; Sheue-Yann Cheng
Journal:  Horm Cancer       Date:  2018-01-19       Impact factor: 3.869

2.  Prognostic significance of promoter CpG island methylation of obesity-related genes in patients with nonmetastatic renal cell carcinoma.

Authors:  Julia Mendoza-Pérez; Jian Gu; Luis A Herrera; Nizar M Tannir; Shanyu Zhang; Surena Matin; Jose A Karam; Christopher G Wood; Xifeng Wu
Journal:  Cancer       Date:  2017-05-23       Impact factor: 6.860

Review 3.  Insights into genetic and epigenetic determinants with impact on vitamin d signaling and cancer association studies: the case of thyroid cancer.

Authors:  Grégoire B Morand; Sabrina Daniela da Silva; Michael P Hier; Moulay A Alaoui-Jamali
Journal:  Front Oncol       Date:  2014-11-04       Impact factor: 6.244

4.  Novel leptin OB3 peptide-induced signaling and progression in thyroid cancers: Comparison with leptin.

Authors:  Yu-Chen Sh Yang; Yu-Tang Chin; Meng-Ti Hsieh; Hsuan-Yu Lai; Chien-Chih Ke; Dana R Crawford; Oscar K Lee; Earl Fu; Shaker A Mousa; Patricia Grasso; Leroy F Liu; Heng-Yu Chang; Heng-Yuan Tang; Hung-Yun Lin; Paul J Davis
Journal:  Oncotarget       Date:  2016-05-10

5.  Association between adipokines and thyroid carcinoma: a meta-analysis of case-control studies.

Authors:  Junyu Zhao; Jing Wen; Shengnan Wang; Jinming Yao; Lin Liao; Jianjun Dong
Journal:  BMC Cancer       Date:  2020-08-20       Impact factor: 4.430

6.  Circulating adipokines and metabolic setting in differentiated thyroid cancer.

Authors:  Chiara Mele; Maria Teresa Samà; Alessandro Angelo Bisoffi; Marina Caputo; Valentina Bullara; Stefania Mai; Gillian Elisabeth Walker; Flavia Prodam; Paolo Marzullo; Gianluca Aimaretti; Loredana Pagano
Journal:  Endocr Connect       Date:  2019-07       Impact factor: 3.335

7.  Clinicopathological implications of leptin and leptin receptor expression in papillary thyroid cancer.

Authors:  Guo-An Zhang; Sen Hou; Sha Han; Jian Zhou; Xu Wang; Wen Cui
Journal:  Oncol Lett       Date:  2013-01-10       Impact factor: 2.967

Review 8.  Renal Cell Cancer and Obesity.

Authors:  Anna Gluba-Brzózka; Jacek Rysz; Janusz Ławiński; Beata Franczyk
Journal:  Int J Mol Sci       Date:  2022-03-21       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.